Trial · NCT02918019
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| SECONDARY | Absolute Change in Pre-Bronchodilator Forced Expiratory Volume in 1 Second (FEV1) | Baseline to Week 54 | Milliliters (mL) | MEAN | |
| SECONDARY | Time to First Asthma Exacerbation | 52 Weeks | Weeks | MEDIAN | |
| SECONDARY | Achievement in Improvement in Standardized Asthma Quality-of-Life Questionnaire (AQLQ(S)) Score | Week 54 | Percentage | NUMBER | |
| SECONDARY | Absolute Change in Patient-Reported Use of Short-Acting Rescue Therapy | Baseline to Week 54 | Usage | MEAN | |
| SECONDARY | Proportion of Weeks Without Patient-Reported Asthma-Related Nighttime Awakenings | Baseline through Week 54 | Percentage of weeks | MEAN | |
| SECONDARY | Absolute Change in Patient-Reported Daytime Asthma Symptom Severity as Measured by the Asthma Daily Symptom Diary (ADSD) | Baseline to Week 54 | Scores on a scale | MEAN | |
| SECONDARY | Percentage of Participants With Adverse Events | Baseline to Week 54 | Percentage | NUMBER | |
| SECONDARY | Percentage of Participants With Anti-Drug Antibodies (ADAs) | Baseline | Percentage | NUMBER | |
| SECONDARY | Serum Concentration of Astegolimab (MSTT1041A) | Weeks 26 and 54 | The analysis population consisted of all PK-evaluable participants with at least one serum PK collected for the given treatment. | ug/mL | GEOMETRIC_MEAN |
| SECONDARY | Percentage of Participants With Treatment-Emergent ADAs | From baseline to the first appearance of ADAs at any point post-baseline (up to Week 54) | Percentage | NUMBER | |
| PRIMARY | Reduction in Rate of Asthma Exacerbations | Baseline to Week 54 | Number of asthma exacerbations per year | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02918019/outcomes